PHARMA LIGHT

International Pharmaceutical Business, Technology, FDA Rules and Regulations, MHRA and other News for Indian Pharmacists, Pharmaceutical Companies.

Pages

▼

Showing posts with label Non Small Cell Lung Cancer. Show all posts

Showing posts with label Non Small Cell Lung Cancer. Show all posts

FDA grants Alecensa accelerated approval for people with a specific type of lung cancer

Roche announced that the US Food and Drug Administration (FDA) granted accelerated approval to Alecensa® (alectinib) for the treatment of p...

Chugai Launches of the ALK Inhibitor Alecensa

Chugai Pharmaceutical Co., Ltd. announced that it obtained approval from the Ministry of Health, Labour and Welfare on September 2, 2015 ...

TAGRISSO approved by the US FDA

AstraZeneca announced that the US Food and Drug Administration (FDA) has approved TAGRISSO™ (AZD9291) 80mg once-daily tablets for the trea...

Boehringer Ingelheim initiates efficacy and safety of BI 1482694

Boehringer Ingelheim announced at the BIO-Europe® conference in Munich, Germany, the initiation of a global Phase II trial evaluating the ...

AstraZeneca Presents Evidence of AZD9291 in Non-Small Cell Lung Cancer

AstraZeneca today announced updated, encouraging data on AZD9291 (osimertinib) in first-line patients with epidermal growth factor ...

View web version

Powered by Blogger.